Rx00128 - Immuneglobulin Intravenous (Human)

Interactive Drug Target Network

Interactive Bipartite Drug Repurposing Graph

Primary Indication
Secondary Indication

Disease prevalence from Electronic Health Records

Click row to show all

Disease A Disease B A∩B A∩¬B B∩¬A Odds-Ratio P-Value Adjusted P-Value
adult Primary Immunodeficiency Primary Humoral Immunodeficiency 192 846 2315 395.563 0 0.0
adult severe combined immunodeficiencies Primary Humoral Immunodeficiency 192 846 2315 395.563 0 0.0
adult common variable immunodeficiency common variable immunodeficiency 623 623 623 6476.604 0 0.0
adult X-linked agammaglobulinemia Primary Humoral Immunodeficiency 55 55 2315 1742.948 9.59E-147 3.08e-143
adult Wiskott-Aldrich syndrome Wiskott-Aldrich Syndrome 10 10 10 403492.4 1.08E-49 3.48e-46

Chemical, Pharmacological and Biological Annotations

ATC Code:
J06BA02 J06BA01;
Civacir; Flebogamma (Instituto Grifols SA); Gamunex (Talecris Biotherapeutics)
Immunologic Factors; Immunosuppressive Agents; Anti-Infective Agents
Organic Compounds
Organic Acids
Carboxylic Acids and Derivatives
Amino Acids, Peptides, and Analogues
IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders. These indications includes idiopathic thrombocytopenic purpura, Kawasaki disease, hypogammaglobulinemia, B cell chronic lymphocytic leuke...
Click to show more...
Used as a replacement therapy in inherited humoral immunodeficiency disorders such as severe combined immunodeficiency syndrome, x-linked agammaglobulinemia, and Wiskott-Aldrich Syndrome. The immunoglobulins target, bind and kill bacterial ...
Click to show more...
Intravenous immunoglobulin (IVIg) is a mixture of IgG1 and other antibodies derived from healthy human plasma via Cohn fractionation. The purification process includes cold alcohol fractionation, polyethylene glycol precipitation, and ion e...
Click to show more...
IVIg interacts with a number of different components of the immune system, including cytokines, complement, Fc receptors and several cell surface immunocompetent molecules. IVIg also impacts different effector cells of the immune system (B ...
Click to show more...

Adsorption, Distribution, Metabolism, Excretion and Toxicity

Not Available from DrugBank

Contact Us:
Please contact us if you have questions or comments about RepurposeDB. You can also contact us if you need help in submitting your drug repositioning investigation to RepurposeDB.

Dudley Laboratory
Department of Genetics and Genomic Sciences
Icahn Institute for Genomics and Multiscale Biology
Icahn School of Medicine at Mount Sinai
One Gustave L. Levy Place, Box 1498
Manhattan, New York City, NY